Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXL2BV
|
||||
Drug Name |
1,2,3,6-tetrahydro-1-(2,2,2-trifluoroethyl)-9-(trifluoromethyl)-7H-[1,4]oxazino[3,2-g]quinolin-7-one
|
||||
Synonyms |
CHEMBL227783
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C14H10F6N2O2
|
||||
Canonical SMILES |
FC(F)(F)CN1CCOc2cc3NC(=O)C=C(c3cc12)C(F)(F)F
|
||||
InChI |
InChI=1S/C14H10F6N2O2/c15-13(16,17)6-22-1-2-24-11-5-9-7(3-10(11)22)8(14(18,19)20)4-12(23)21-9/h3-5H,1-2,6H2,(H,21,23)
|
||||
InChIKey |
DKTPAKMQCCCINA-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Progesterone receptor | Target Info | [1587926] | ||
mRNA of androgen receptor | Target Info | [1587926] | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinsmad2_3nuclearpathway:Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.